Drug Chatter -- Tracking biopharma stock chatter

Profile for Akebia Therapeutics, Inc. (AKBA)

« Back to company index

AKBA Chatter Timeline

Stock Ticker for AKBA

Most Active Tweeters for AKBA

UserTweets
@brockthornhill 3
@timeout2575 2
@n_yigitbasi 2
@MaisaCorp 2
@biostockfan 1

Recent Tweets for AKBA

ChartMill @ChartMill
Although the technical rating is only medium, $AKBA does present a nice setup opportunity. We see reduced volat ...… https://t.co/nO1pHEvxoe
January 15th 2018, 8:01am
WeekHerald @WeekHerald
Akebia Therapeutics $AKBA Getting Somewhat Favorable Press Coverage, Report Finds https://t.co/UcjqZLL2P8
January 12th 2018, 8:01am
TheMarketsDaily @TheMarketsDaily
Schwab Charles Investment Management Inc. Purchases 31,857 Shares of Akebia Therapeutics Inc $AKBA https://t.co/WQwnT7ekW4
January 11th 2018, 6:01am
Gupta_Calling @Gupta_Calling
$AKBA 5.75 % Form SC 13G/A Akebia Therapeutics, Filed by: EAGLE ASSET MANAGEMENT INC https://t.co/syo3efdc1u
January 8th 2018, 12:01pm
fintel_io @fintel_io
Eagle Asset Management Inc has filed an amended 13G/A, reporting 5.75% ownership in $AKBA - https://t.co/jcBjb9wPlG
January 8th 2018, 11:01am
confcalltran @confcalltran
Statement of acquisition of beneficial ownership by individuals https://t.co/ivpE56nB4R $AKBA
January 8th 2018, 11:01am
filingBot @filingBot
@altafmubaraki there is a new form SC 13G/A filing for $AKBA https://t.co/Mfxc7nEg06 What do you think?
January 8th 2018, 11:01am
brockthornhill @brockthornhill
RT @skaushi: JMP $AKBA announced positive top-line data from a Phase II trial of vadadustat in Japanese patients with anemia and dialysis-d…
January 5th 2018, 2:01pm
skaushi @skaushi
JMP $AKBA announced positive top-line data from a Phase II trial of vadadustat in Japanese patients with anemia and… https://t.co/CKtWCv96sV
January 5th 2018, 2:01pm
TribuneTrueBlue @TribuneTrueBlue
Zacks Investment Research Lowers Akebia Therapeutics $AKBA to Hold https://t.co/CPmMxUyDOR
January 5th 2018, 11:01am
Lblegend33 @Lblegend33
@JasonHolman5 Don’t think was $akba news as much Bc akba went down. Chart showed going to lower level of cloud (47.… https://t.co/9xgiE636jS
January 4th 2018, 4:01pm
JasonHolman5 @JasonHolman5
At a loss on $FGEN trading ? off $AKBA good news. IMO creates near term add opps. Good to track,but attempting to a… https://t.co/i64ci0LcuC
January 4th 2018, 4:01pm
SEEKINGALPHA_FS @SEEKINGALPHA_FS
Akebia's vadadustat shows positive results in Japan-based anemia study https://t.co/iI1laCEKPg $AKBA
January 4th 2018, 10:01am
MarketCurrents @MarketCurrents
Akebia's vadadustat shows positive results in Japan-based anemia study https://t.co/y9hwPyA1SF $AKBA
January 4th 2018, 10:01am
Briefingcom @Briefingcom
$AKBA: Akebia Therapeutics announces 'positive' results from its Phase 2 study of vadadustat in patients with anemi… https://t.co/VmwXywJSw0
January 4th 2018, 9:01am
brockthornhill @brockthornhill
RT @odibro: $AKBA Announces Positive Top-Line Results from Phase 2 Study of Vadadustat in Japanese Patients with Anemia Associated with Dia…
January 4th 2018, 8:01am
brockthornhill @brockthornhill
RT @Lin_ling_88: $AKBA announced top-line results from its Ph2 study of vadadustat in pts w/anemia assoc with dialysis-dependent chronic ki…
January 4th 2018, 8:01am
biostockfan @biostockfan
RT @BioStocks: $AKBA Announces Positive Top-Line Results From Phase 2 Study of Vadadustat in Japanese Patients With Anemia Associated With…
January 4th 2018, 7:01am
crwenewswire @crwenewswire
$AKBA Reveals findings from mid-sateg study evaluating Vadadustat in Japanese patients with anemia https://t.co/lCYrDju17H
January 4th 2018, 7:01am
n_yigitbasi @n_yigitbasi
$AKBA announced top-line results from its Ph2 study of vadadustat in pts w/anemia assoc with dialysis-dependent chr… https://t.co/hCRyXMW3h8
January 4th 2018, 7:01am
timeout2575 @timeout2575
RT @MaisaCorp: $AKBA Positive Results From Study Of Vadadustat In Japanese. ?PHASE 3 STUDY OF NON-DIALYSIS PATIENTS IN JAPAN ONGOING; PHASE…
January 4th 2018, 7:01am
MaisaCorp @MaisaCorp
$AKBA Positive Results From Study Of Vadadustat In Japanese. ?PHASE 3 STUDY OF NON-DIALYSIS PATIENTS IN JAPAN ONGOI… https://t.co/Pn0ezHzQ5z
January 4th 2018, 7:01am
Lin_ling_88 @Lin_ling_88
$AKBA announced top-line results from its Ph2 study of vadadustat in pts w/anemia assoc with dialysis-dependent chr… https://t.co/eoc3t79Z0K
January 4th 2018, 7:01am
n_yigitbasi @n_yigitbasi
$AKBA Announces Positive Top-Line Results from Phase 2 Study of Vadadustat in Japanese Patients with Anemia Associa… https://t.co/1Zz4eT552U
January 4th 2018, 7:01am
odibro @odibro
$AKBA Announces Positive Top-Line Results from Phase 2 Study of Vadadustat in Japanese Patients with Anemia Associa… https://t.co/s4iLVtYkn4
January 4th 2018, 7:01am
timeout2575 @timeout2575
RT @MaisaCorp: $AKBA Will Receive $10M in Milestone Payments in Conjunction With the Start of the Phase 3 Studies
January 4th 2018, 7:01am
stocknewsdotcom @stocknewsdotcom
$AKBA Announces 'positive' results from its Phase 2 study of vadadustat in patients with anemia associated with … https://t.co/fkSP62E97o
January 4th 2018, 7:01am
stockboardinc @stockboardinc
$AKBA Akebia Therapeutics Announces Positive Top-Line Results from Phase 2 Study of Vadadustat in Japanese... - https://t.co/MaXMxwMnNq
January 4th 2018, 7:01am
newswithvalue @newswithvalue
$AKBA: Akebia Therapeutics Announces Positive Top-Line Results from …: https://t.co/MAwTt1sVdP
January 4th 2018, 7:01am
MaisaCorp @MaisaCorp
$AKBA Will Receive $10M in Milestone Payments in Conjunction With the Start of the Phase 3 Studies
January 4th 2018, 7:01am
BioStocks @BioStocks
$AKBA Announces Positive Top-Line Results From Phase 2 Study of Vadadustat in Japanese Patients With Anemia Associa… https://t.co/SLVVk7Ez4f
January 4th 2018, 7:01am
TV_TradingIdeas @TV_TradingIdeas
**UPDATE** AKBA play, I like this mor\u2026 $AKBA https://t.co/unesG1opLL
January 4th 2018, 1:01am
luchotrader76 @luchotrader76
**UPDATE** AKBA play, I like this more and more - $AKBA chart https://t.co/NiUCyS1Ao3
January 4th 2018, 1:01am
intercooleronli @intercooleronli
Akebia Therapeutics $AKBA Stock Rating Lowered by Zacks Investment Research https://t.co/f40Rf7v6ND
January 2nd 2018, 6:01pm
CFinancialNews @CFinancialNews
Akebia Therapeutics $AKBA Stock Rating Lowered by Zacks Investment Research https://t.co/WznNWktxrG
January 2nd 2018, 6:01pm
AmericanBanking @AmericanBanking
Akebia Therapeutics downgraded by Zacks Investment Research to hold. https://t.co/K52BcZvHyD $AKBA #AKBA
January 2nd 2018, 5:01pm
RatingsNetwork @RatingsNetwork
Akebia Therapeutics downgraded by Zacks Investment Research to hold. https://t.co/XLi9yhm7Rs $AKBA #AKBA
January 2nd 2018, 5:01pm
TheMarketsDaily @TheMarketsDaily
Zacks Investment Research Downgrades Akebia Therapeutics $AKBA to Hold https://t.co/ncqtHbJVAl
January 2nd 2018, 5:01pm
ConsumerFeed @ConsumerFeed
Akebia Therapeutics downgraded by Zacks Investment Research to hold. https://t.co/uVVh8DPYd7 $AKBA #AKBA
January 2nd 2018, 5:01pm
stockboardinc @stockboardinc
$AKBA Akebia Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)... - https://t.co/A3pkMkLwMz
January 2nd 2018, 4:01pm
redacre @redacre
@salinaro17 applicable to $AKBA as well
January 2nd 2018, 1:01pm
MariaDa18810214 @MariaDa18810214
Nantahala Capital Management Decreased Its Akebia Therapeutics $AKBA Position as Stock Rose ...
January 2nd 2018, 11:01am
stocknewstimes @stocknewstimes
Akebia Therapeutics $AKBA Coverage Initiated at Piper Jaffray Companies https://t.co/5UWNofEdZD
January 2nd 2018, 11:01am
SleekMoneycom @SleekMoneycom
Akebia Therapeutics $AKBA Coverage Initiated at Piper Jaffray Companies https://t.co/oT5Gs7VVxo
January 2nd 2018, 11:01am
stocknewstimes @stocknewstimes
Somewhat Favorable News Coverage Somewhat Unlikely to Affect Akebia Therapeutics $AKBA Stock Price https://t.co/f83xYDPMba
January 2nd 2018, 7:01am
MariaDa18810214 @MariaDa18810214
Eagle Asset Management Trimmed Its Akebia Therapeutics $AKBA Holding by $9.15 Million https://t.co/nUwQNmXJJk
January 1st 2018, 11:01am
AmericanBanking @AmericanBanking
Akebia Therapeutics Inc $AKBA Given Average Recommendation of “Buy” by Analysts https://t.co/aHUSzGQAm9
January 1st 2018, 8:01am
intercooleronli @intercooleronli
Akebia Therapeutics Inc $AKBA Given Average Recommendation of “Buy” by Analysts https://t.co/CIgIaAJf7m
January 1st 2018, 8:01am
TheMarketsDaily @TheMarketsDaily
Akebia Therapeutics Inc $AKBA Given Average Recommendation of “Buy” by Analysts https://t.co/zZLZhp27cB
January 1st 2018, 8:01am
CFinancialNews @CFinancialNews
Akebia Therapeutics Inc $AKBA Given Average Recommendation of “Buy” by Analysts https://t.co/Np9UT2Noso
January 1st 2018, 8:01am

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.